| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/19/2005 | EP1463942A4 Methods for purifying protein |
| 01/19/2005 | EP1307113A4 Oil seed processing |
| 01/19/2005 | EP1070081A4 Novel molecules of the t129-related protein family and uses thereof |
| 01/19/2005 | EP1034298A4 Humanization of murine antibody |
| 01/19/2005 | EP0918863B1 Frozen food product containing heat stable antifreeze protein |
| 01/19/2005 | EP0888461A4 Tissue remodeling proteins |
| 01/19/2005 | EP0821737A4 NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF |
| 01/19/2005 | EP0789588B1 Method for making a medicament for treating secondary immunodeficiency |
| 01/19/2005 | CN1568373A RNA interference mediating small rna molecules |
| 01/19/2005 | CN1568369A Hybrid interferon/interferon Tau proteins, compositions and methods of use |
| 01/19/2005 | CN1568331A Biological products |
| 01/19/2005 | CN1568330A Glycosylphosphatidylinositol containing polypeptides |
| 01/19/2005 | CN1568329A Immunogenic peptide composition for the prevention and treatment of Alzheimer's disease |
| 01/19/2005 | CN1568222A Solid compositions for selective adsorption from complex mixtures |
| 01/19/2005 | CN1567597A Method for improving photoelectric conversion capability of bacteriorhodopsin film pulse |
| 01/19/2005 | CN1566358A Enzymolysis product of animal brain and its preparation method and pharmaceutical use |
| 01/19/2005 | CN1566357A Preparation method of recombinant mutant human tumor necrosis factor |
| 01/19/2005 | CN1566356A Method for preparing earthworm bioactive peptide and earthworm biological micro-fertilizer and use thereof |
| 01/19/2005 | CN1566341A In vitro molecular directed evolution method for reshaping antibody |
| 01/19/2005 | CN1566338A Unhairing protease and polynucleotide encoding same |
| 01/19/2005 | CN1566158A Recombinant vaccine for prevention and treatment of SARS virus |
| 01/19/2005 | CN1566156A Recombinant target fusion protein GnRH-TNFam and its antitumor use |
| 01/19/2005 | CN1566154A Novel hepatocyte growth factor, preparing process and application thereof |
| 01/19/2005 | CN1566152A Immunoreactive peptide Trpi possessing antibacterial action |
| 01/19/2005 | CN1566148A Tumor suppressor, coded protein and application thereof |
| 01/19/2005 | CN1566146A Paddy rice stalk extension gene, coded protein and application thereof |
| 01/19/2005 | CN1185348C Chimeric interleukin-6 soluble receptor/ligand protein and application thereof |
| 01/19/2005 | CN1185344C Protein for blocking platelet adhesion |
| 01/19/2005 | CN1185343C New growth-differentiation factor of the TGF-beta family |
| 01/19/2005 | CN1185255C Compositions and Methods for detecting treponema pallidum |
| 01/18/2005 | US6844422 Inhibitor protein of the wnt signal pathway |
| 01/18/2005 | US6844191 Osteogenic cell growth using a TGFβ1-von Willebrand's factor fusion protein |
| 01/18/2005 | US6844190 Binding protein for use in the treatment of pain, schizophrenia, depression, obsessive compulsive disorder, anxiety, migraines and pain |
| 01/18/2005 | US6844189 Chromosome 17P-linked prostate cancer susceptibility gene |
| 01/18/2005 | US6844171 Oligomerization of hepatitis delta antigen |
| 01/18/2005 | US6844169 Producing transgenic eschericheria as bioreator for controlling expression of heterologous proteins within trytpphan operon |
| 01/18/2005 | US6844164 Antibody against rat postacrosome reaction sperm and utilization thereof |
| 01/18/2005 | US6844162 Identifying imunoglobulins associated with thyroid stimulating hormone receptor (TRAB) for diagnosing and treating graves' and glandular disorders |
| 01/18/2005 | US6843999 Streptococcal ABC transporter protein |
| 01/18/2005 | US6843989 Administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand |
| 01/18/2005 | CA2144043C Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/13/2005 | WO2005003341A1 Cell-free protein synthesizing method by continuous energy supply system using intracellular component |
| 01/13/2005 | WO2005003326A2 Artificial receptors including reversibly immobilized building blocks and methods |
| 01/13/2005 | WO2005003322A2 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 01/13/2005 | WO2005003313A2 Methods and compositions for enhanced protein expression and purification |
| 01/13/2005 | WO2005003299A2 Polynucleotides encoding novel guanylate binding proteins (gbp's) |
| 01/13/2005 | WO2005003296A2 Albumin fusion proteins |
| 01/13/2005 | WO2005003294A2 Unnatural reactive amino acid genetic code additions |
| 01/13/2005 | WO2005003289A2 Ap1 amine oxidase variants |
| 01/13/2005 | WO2005003159A1 Complement depletion using recombinant human c3-derivatives |
| 01/13/2005 | WO2005002529A2 Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
| 01/13/2005 | WO2005002502A2 An assay for detecting the presence of processing inhibitory antibodies against the apical membrane antigene-1 of plasmodium falciparum in biological samples |
| 01/13/2005 | WO2005002359A2 Modified starch, uses, methods for production thereof |
| 01/13/2005 | WO2004069191A3 Identification of t1r and t2r modulators |
| 01/13/2005 | WO2004024097A8 Compositions and methods for the treatment of immune related diseases |
| 01/13/2005 | WO2003074073A3 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 01/13/2005 | WO2003017943A3 Therapeutic compositions and methods for treating viral infection |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |
| 01/13/2005 | US20050010037 Metalloprotease expressed in transgenic plant cells for use as additive to enhance nutrient quality of animal feeds |
| 01/13/2005 | US20050010028 High throughput screening; genomics; proteomics |
| 01/13/2005 | US20050009747 High purity lipopeptides |
| 01/13/2005 | US20050009745 TSG101 as inhibitor of HIV production |
| 01/13/2005 | US20050009150 Humanized antibodies that recognize beta amyloid peptide |
| 01/13/2005 | US20050009149 Trimeric tumor necrosis factor receptors for use as modulator for treatment of rheumatoid arthritis, atherosclerosis, osteoporosis, allograft rejection, cancer, inflammatory bowel and autoimmune diseases |
| 01/13/2005 | US20050009148 Preparing recombinant, preferentially glycosylated antihemophilic factor for use in treating blood disorders and hemophilia |
| 01/13/2005 | US20050009147 Parathyroid hormone variants; site-directed mutagenesis; for treatment of bone disorders |
| 01/13/2005 | US20050009141 Epidermal differentiation factor |
| 01/13/2005 | US20050009140 Elongase genes and uses thereof |
| 01/13/2005 | US20050009139 Compositions and methods for generating chimeric heteromultimers |
| 01/13/2005 | US20050009085 44 Human secreted proteins |
| 01/13/2005 | US20050009084 Detection of polymorphisms in the human 5-lipoxygenase gene |
| 01/13/2005 | US20050009062 Phosphodiesterase 10 |
| 01/13/2005 | US20050009057 Using apical membrane antigen-1 as a diagnostic and therapeutic aide in treatment and prevention of plasmodium infection; immunotherapy; antimalarial agents |
| 01/13/2005 | US20050009049 Expanding the eukaryotic genetic code |
| 01/13/2005 | US20050009025 A soluble T cell receptor for use as diagnostic indicator of infection and autoimmune diseases |
| 01/13/2005 | US20050009013 Preparing transfer RNA-coumarin marker conjugates for non-radioactive detection and analysis of translation |
| 01/13/2005 | US20050008654 For prevention, therapy of sepsis shock, thrombosis disorders |
| 01/13/2005 | US20050008650 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 01/13/2005 | US20050008645 Antibodies Specific For Phosphatase Subunit of LAR |
| 01/13/2005 | US20050008637 Cancer therapy; antiinflammatory agents; autoimmune disease |
| 01/13/2005 | US20050008635 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods |
| 01/13/2005 | CA2531321A1 Rna processing protein complexes and uses thereof |
| 01/13/2005 | CA2530530A1 Methods and compositions for enhanced protein expression and purification |
| 01/13/2005 | CA2527877A1 Unnatural reactive amino acid genetic code additions |
| 01/13/2005 | CA2527089A1 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 01/13/2005 | CA2526480A1 Modified starch, uses, methods for production thereof |
| 01/13/2005 | CA2520224A1 Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
| 01/13/2005 | CA2513213A1 Albumin fusion proteins |
| 01/13/2005 | CA2494798A1 Ap1 amine oxidase variants |
| 01/12/2005 | EP1496364A2 Cloning and expression of gonadotropin-releasing hormone receptor |
| 01/12/2005 | EP1496110A1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes |
| 01/12/2005 | EP1496066A1 Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells |
| 01/12/2005 | EP1495123A1 Erbb3 based methods and compositions for treating neoplasms |
| 01/12/2005 | EP1495112A2 Cell culture medium |
| 01/12/2005 | EP1495110A1 Recombinant spores |
| 01/12/2005 | EP1495056A1 Antibody disulfide isomers, use thereof, and methods of analyzing same |
| 01/12/2005 | EP1495054A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 01/12/2005 | EP1495053A2 Angiopoietin-2 specific binding agents |
| 01/12/2005 | EP1495052A1 Modified factor viii |
| 01/12/2005 | EP1494722A1 Treatment methods for eotaxin mediated inflammatory conditions |